MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

Similar documents
Symptom Management Guidelines for End of Life Care

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

Care in the Last Days of Life

Renal Palliative Care Last Days of Life

Algorithms for Symptom Management. In End of Life Care

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

Supportive Care. End of Life Phase

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

End of life prescribing guidance

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

SYRINGE DRIVER MEDICATIONS

Syringe driver in Palliative Care

Palliative care for heart failure patients. Susan Addie

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Care of dying adults in the last days of life. Improving care at the very end of life.

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

The last days of life in hospital and at home

MND Just in Case kit Information for GPs

Implementing the recommendation on medication management and symptom control

Palliative Prescribing - Pain

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

Using syringe pumps in palliative care

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.

Approach to symptom control near the end-of-life

Syringe Drivers. Back to top

Palliative Care Impact Survey

CLINICAL GUIDELINES FOR END OF LIFE CARE MEDICATIONS IN LONG TERM CARE HOMES

Coversheet for Network Site Specific Group Agreed Documentation

Conservative Management of Uraemia

Clatterbridge Centre for Oncology

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

End Stage Liver Disease Regional Audit Casenote Survey

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT

Regional Renal Training

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Target audience: The target audience for this guidance are: GPs Care home managers and nurses, District nurses, and Specialist Palliative Care teams.

BJF Acute Pain Team Formulary Group

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza


GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline

Agitation. Susan Emmens Palliative Care Clinical Nurse Specialist

Palliative care in long-term conditions Scottish Palliative Care Pharmacists Association

The John Walls Renal Unit Leicester General Hospital University Hospitals of Leicester

Opioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects.

Understanding pain in 5 minutes

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group

Ventilation/End of Life Neuromuscular Disorders. Dr Emma Husbands Consultant Palliative Medicine

This survey aims to look at individual practice and can be completed by any healthcare professional.

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

BREATHLESSNESS MANAGEMENT

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

Controlled Document Number: Version Number: 1. Controlled Document Sponsor: Controlled Document Lead (Author): On: July Review Date: July 2020

Palliative Care. Pocketbook 4

Restlessness Emotional support Self care

Lothian Palliative Care Guidelines POCKET EDITION 2004

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC

BACKGROUND Measuring renal function :

Emergency Control of the Acutely Disturbed Adult Patient GUIDELINES ON EMERGENCY CONTROL OF THE ACUTELY DISTURBED ADULT PATIENT... 2 ACTION...

Treating the symptoms of kidney failure

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services

Care of the Dying: Is Pain Control Compromised or Enhanced by Continuation of the Fentanyl Transdermal Patch in the Dying Phase?

Eastern Health and Social Services Board Palliative Care

NHS Grampian. Care Plan Palliative & Supportive. Acute Care Settings

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Palliative Care Formulary

Opioid Conversion Guidelines

SYMPTOM CONTROL MEDICATION & THE DYING PERSON LITERATURE REVIEW, & DRAFT NEW STANDARDS & GUIDELINES

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

Palliative Emergencies. Ken Stakiw

GUIDELINES FOR CONVERSION FROM A STRONG OPIOID TO METHADONE

Managing Care at End of Life:

Palliative care for patients with brain cancer

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

General Palliative Care Guidelines for the Management of Pain at the End of Life in Adult Patients

Pain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan

Care of the dying in End Stage Kidney Disease (ESKD) - Conservative. Elizabeth Josland Renal Supportive Care CNC St George Hospital

Transcription:

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be in the last few days and hours of life. They are based on a review of the Palliative Adult Network Guidelines (2011) 1, Palliative Care Formulary (2011) 2 and clinical consensus from rthamptonshire Specialist Palliative Care Service. These guidelines do not replace clinical judgement. Full explanation and negotiation with the patient and their important others is essential. The prescriber must consider the following points when prescribing, as well as: - other medication, age, frailty, renal impairment and co-morbidities. 1. Consider how symptoms can be improved without using drugs: - Are there any underlying causes that need to be managed? For example - urinary retention can cause agitation. Are drugs the best treatment? For example - would changing the patient s position help noisy respiratory secretions? 2. Assume that the oral route will not be possible, if not immediately, then in the near future. 3. Anticipatory prescribing for symptoms that commonly develop in the last few days and hours of life will ensure that there is no delay in responding to a symptom as it occurs. 4. Symptoms can change frequently and rapidly. Regular assessment of the patient and review of the effect of interventions is crucial. 5. Medications given by a (s/c) infusion via a syringe pump take approximately 6 hours to reach a therapeutic level. If the patient is symptomatic at the time the infusion is commenced an appropriate as (PRN) dose of medication should also be administered. 6. Medication should be prescribed via the route. This ensures that the drug is absorbed and it is a route of administration that is possible in the majority of settings; please refer to your organisation s policy for the use of syringe pumps. 7. If the patient was previously taking opioid medication other than morphine, then their original opioid would be the drug of choice for a infusion via a syringe pump; seek specialist advice for dose conversions before prescribing. 8. If the patient was previously prescribed a fentanyl or buprenorphine patch, the patch should be continued. If increasing pain develops and their background opioid dose needs to be increased, a infusion via a syringe pump can be added; seek specialist advice before prescribing. If symptoms are not adequately controlled or side effects are intolerable contact Cynthia Spencer Hospice (01604) 678031 or Cransley Hospice (01536) 452019 1. Watson M, et al (2011). Palliative Adult Network Guidelines United Kingdom. Max Watson. 3 rd Ed. 2. Twycross R & Wilcock A (2014). Palliative Care Formulary United Kingdom. palliativedrugs.com 5 th Ed. Approved by NHFT Medicines Management Committee September 2014 Reviewed December 2016 Review Jan 2019 MMG035 NHFT End of Life Medication Guidelines (Jan17-Jan19) Page 1 of 7

The Management of Pain with MORPHINE in the Last Few Days of Life Is the patient in pain? Is the patient prescribed regular Is the patient prescribed regular Prescribe in anticipation of the symptom developing: Morphine If symptom develops follow guidelines as for a patient who has pain To convert a patient from oral morphine to a infusion of morphine, divide the total daily dose of oral morphine by 2 [e.g. If a patient is taking 60mg oral morphine daily, (e.g. Zomorph, MST or Morphgesic 30mg 12hourly) start a infusion of 30mg morphine via syringe pump over 24 hours] Prescribe PRN morphine at one sixth of the 24 hour dose as [e.g. A patient prescribed a infusion of 30mg morphine via syringe pump over 24 hours requires 5mg morphine PRN by injection] If two or more breakthrough doses of morphine have been given in a 24 hour period, increase the total daily dose in the syringe pump by the equivalent amount and recalculate the new breakthrough dose of morphine as described above Prescribe morphine After 24 hours, review medication If two or more PRN doses have been given, consider a syringe pump Assuming absorption is not impaired, the current morphine dose is insufficient to control symptoms To convert from oral morphine to a infusion of morphine, divide the total daily dose of oral morphine by 2 and then increase this dose by 30%; this will result in an appropriate increase in analgesic [e.g. 60mg oral morphine over 24 hours (Zomorph, MST or Morphgesic 30mg 12hourly) converts to a infusion of 40mg morphine via a syringe pump over 24 hours] Prescribe PRN morphine at one sixth of the 24 hour dose as [e.g. A patient prescribed a infusion of 30mg morphine via syringe pump over 24 hours requires 5mg morphine by injection] Give a stat dose of morphine (one sixth of the total daily dose) whilst the syringe pump is being set up Patients who have not taken an opioid before should be prescribed haloperidol 1.5mg PRN as an anti-emetic In patients who are uncomfortable because of stiffness and those not previously on opioids consider rectal or diclofenac ( 50mg - 100mg PRN max 150mgs 24hrs) Although the appropriate dose of morphine is not weight related lower starting doses (i.e. 2.5mg stat ) should be used in patients that are elderly, cachectic or have dementia. Those patients with renal impairment should also start at the lower dose in a range Morphine is the medication of first choice. For patients on very high doses (>500mg/24hr ) diamorphine might be : seek specialist advice To convert oral morphine to diamorphine, divide the oral morphine dose by 3 MMG035 NHFT End of Life Medication Guidelines (Jan17-Jan19) Page 2 of 7 If symptoms are not adequately controlled or side effects are intolerable contact Cynthia

The Management of Pain with DIAMORPHINE in the Last Few Days of Life Is the patient in pain? NB: Morphine is the medication of first choice Is the patient prescribed regular Is the patient prescribed regular Prescribe in anticipation of the symptom developing: Diamorphine If symptom develops, follow guidelines as for a patient who has pain To convert a patient from oral morphine to a infusion of diamorphine, divide the total daily dose of oral morphine by 3 [e.g. If a patient is taking 60mg oral morphine daily, (e.g. Zomorph, MST or Morphgesic 30 mg 12 hourly) start a infusion of 20 mg diamorphine via syringe pump over 24 hours] Prescribe PRN diamorphine at one sixth of the 24 hour dose of diamorphine as [e.g. A patient prescribed a infusion of 20 mg diamorphine via syringe pump over 24 hours requires 3mg diamorphine by injection] If two or more breakthrough doses of diamorphine have been given in a 24 hour period, increase the total daily dose in the syringe pump by the equivalent amount and recalculate the new breakthrough dose of diamorphine as described above. Prescribe diamorphine After 24 hours, review medication If two or more PRN doses have been given, consider a syringe pump Assuming absorption is not impaired, the current oral morphine dose is insufficient to control symptoms To convert to a infusion of diamorphine divide the total daily dose of oral morphine by 3 and then increase this dose by 30%; this will result in an appropriate increase in analgesic [e.g. 60mg oral morphine over 24 hours (Zomorph, MST, or Morphgesic 30mg 12hourly) converts to a infusion of 25mg diamorphine via a syringe pump over 24 hours] Prescribe PRN diamorphine at one sixth of the 24 hour dose of diamorphine as [e.g. A patient prescribed a infusion of 20mg diamorphine via syringe pump over 24 hours requires 3mg diamorphine by injection] Give a stat dose of diamorphine (one sixth of the total daily dose) whilst the syringe pump is being set up Patients who have not taken an opioid before should be prescribed haloperidol 1.5mg PRN as an anti-emetic In patients who are uncomfortable because of stiffness and those not previously on opioids consider rectal or diclofenac (50mg - 100mg PRN max 150mgs 24hrs) Morphine is the medication of first choice: See Management of Pain with Morphine in the Last Few Days flow chart Although the appropriate dose of diamorphine is not weight related lower starting doses (i.e. 2.5mg stat ) should be used in patients that are elderly, cachectic or have dementia. Those patients with renal impairment should also start at the lower dose in a range.

The Management of Restlessness and Agitation in the Last Few Days of Life Is the patient restless or agitated? A human presence often helps to calm agitated patients Prescribe in anticipation of the symptom developing: Midazolam If symptom develops, follow guidelines for a patient who is restless or agitated Consider underlying causes and resolve where possible: Uncontrolled pain Full bladder Full rectum Dyspnoea Anxiety and fear If the patient s distress cannot otherwise be relieved Where anguish and anxiety are predominant: Give midazolam 2.5-5mg stat and as by injection (this may need to be repeated after 30 minutes) If two or more doses have been given in 24 hours, consider starting a infusion of 10mg midazolam via a syringe pump over 24 hours The infusion dose may need to be increased gradually to midazolam 30mg via syringe pump over 24 hours Where delirium and psychotic features are predominant (e.g. hallucinations, confusion): Give haloperidol 1.5mg stat and 0.5 1mg haloperidol as by injection up to a maximum total daily dose of 10mg. Consider giving haloperidol via a infusion over 24 hours Consider a infusion of haloperidol 3mg and midazolam 10mg via a syringe pump over 24 hours if Levomepromazine 12.5-25mg stat by injection is an alternative to haloperidol. Consider a infusion of 50mg via syringe pump over 24 hours if

The Management of Nausea and Vomiting in the Last Few Days of Life Is patient already on an effective antiemetic? Is nausea or vomiting present? Prescribe this antiemetic As infusion over 24hr As PRN dosing Prescribe in anticipation of the symptom developing: Haloperidol 0.5 1mg by injection as If symptom develops, follow guidelines as for a patient who is nauseated or vomiting Give haloperidol 0.5 1mg by Review after 24 hours. If two or more PRN doses of haloperidol have been given, consider starting a infusion of haloperidol 3mg via a syringe pump over 24 hours Maximum total daily dose of haloperidol should not exceed 10mg Alternative antiemetic: Stop haloperidol and prescribe levomepromazine 6.25mg by (or a infusion of 6.25 12.5mg levomepromazine via a syringe pump over 24 hours)

The Management of Respiratory Tract Secretions in the Last Few Days of Life isy respiratory tract secretions can be a normal part of dying Consider whether they are troublesome or need treating at all Changing the patient s position is the first step of management Does the patient have troublesome respiratory tract secretions? Consider: Patient positioning Stopping I.V. or fluids or PEG feed Prescribe in anticipation of the symptom developing: Glycopyrronium 200micrograms by, up to every four hours If symptoms develop, follow guidelines as for a patient who has respiratory tract secretions Give glycopyrronium 400 micrograms by soon as symptom arises and as, up to every four hours If two or more doses of glycopyrronium have been given and are effective, consider starting a infusion of 800micrograms glycopyrronium via syringe pump over 24 hours Review after 24 hours If symptoms persist, increase the total daily dose to a maximum of 1.2mg glycopyrronium over 24 hours In a VERY SMALL number of patients, suction may be helpful This is a difficult symptom to treat and drugs may not be effective - remember to reassure relatives and friends Hyoscine hydrobromide is an alternative but is sedative and frequently causes confusion (400micrograms stat and up to 2.4 mg over 24 hours)

The Management of Dyspnoea in the Last Few Days of Life Does the patient complain of breathlessness? Prescribe in anticipation of the symptom developing: Morphine injection, as and Midazolam 2.5mg by If breathlessness develops, follow guidelines as for a patient who is breathless First considerations: Reposition the patient, e.g. sit up in bed Calm and reassure patient and carers by touch, talking and explanation Keep air moving across the face e.g. open the window, use a fan or try oxygen Is the patient taking regular Give morphine injection. If not sufficiently effective give 2.5mg midazolam by injection. Doses can be repeated every 30 minutes as. Specialist advice should be sought if symptoms persist (e.g. after 3 PRN doses in quick succession) After 24 hours, review medication If two or more PRN doses, consider a syringe pump Assuming absorption is not impaired, the current morphine dose is insufficient to control symptoms To convert a patient from oral morphine to a infusion of morphine divide the total daily dose of oral morphine by 2, and then increase the dose by 30%; this will result in an appropriate increase in the amount of opiate being given Give PRN morphine at one sixth of the 24 hour dose. See The Management of Pain with Morphine in the Last Few Days of Life If not sufficiently effective give 2.5mg midazolam by injection Review after 24 hours. If two or more doses of midazolam have been given, consider starting a infusion of 5-10mg midazolam over 24 hours via a syringe pump Patients who have not taken an opiate before should be prescribed haloperidol 1.5mg PRN as an anti-emetic. Morphine is used for relief of the sensation of dyspnoea; midazolam is used for the relief of anxiety associated with dyspnoea To convert oral morphine to diamorphine, divide the oral morphine dose by 3